For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $22.88 in the prior trading day, Pfizer Inc (NYSE: PFE) closed at $22.79, down -0.39%. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 47.84 million shares were traded.
Ratios:
Our goal is to gain a better understanding of PFE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 22, 2025, initiated with a Neutral rating and assigned the stock a target price of $24.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Underperform rating and target price of $25.Wolfe Research initiated its Underperform rating on November 15, 2024, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 05 ’25 when Dolsten Mikael bought 55,000 shares for $23.87 per share.
DAMICO JENNIFER B. sold 2,500 shares of PFE for $64,825 on Mar 04 ’25. The SVP & Controller now owns 11,850 shares after completing the transaction at $25.93 per share. On Feb 13 ’25, another insider, BLAYLOCK RONALD E, who serves as the Director of the company, bought 19,457 shares for $25.65 each. As a result, the insider paid 499,072 and bolstered with 27,707 shares of the company.
Valuation Measures:
As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.52, and their Forward P/E ratio for the next fiscal year is 7.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 1.43.
Stock Price History:
Over the past 52 weeks, PFE has reached a high of $31.54, while it has fallen to a 52-week low of $20.92. The 50-Day Moving Average of the stock is -6.62%, while the 200-Day Moving Average is calculated to be -15.10%.
Shares Statistics:
A total of 5.68B shares are outstanding, with a floating share count of 5.67B. Insiders hold about 0.06% of the company’s shares, while institutions hold 68.19% stake in the company.
